The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events

Journal of Pain and Symptom Management

Volumn 27, Issue 2, 2004, Pages 185-190

  Rosenzweig, Margaret Q ^a,d   Bender, Catherine M ^a   Lucke, Joseph P ^a   Yasko, Joyce M ^a   Brufsky, Adam M ^b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d University School of Nursing   (United States)

Author keywords

Anemia; Erythropoietin; Metastatic breast cancer; Thrombotic events

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DOSE CALCULATION; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; FEMALE; HEMOGLOBIN DETERMINATION; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; LUNG EMBOLISM; MALE; MEDICAL DECISION MAKING; PATIENT EDUCATION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SAMPLE SIZE; TREATMENT WITHDRAWAL;

EID: 1242338209     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2003.06.010     Document Type: Short Survey

References (15)

1. Ludwig H., Fritz E., Kotzmann H., et al. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med. 322:1990;1693-1699.
2. Platanias L., Miller C., Mick R., et al. Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients. J Clin Oncol. 9:(11):1991;2021-2026.
3. Abels R. Erythropoietin for anemia in cancer patients. Eur J Cancer. 29A:(Supp 2):1993;S2-S8.
4. Henry D., Abels R. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double blind/open label follow up studies. Semin Oncol. 21:(2; Supp 3):1994;21-28.
5. Pawlicki M., Jassem J., Bosze P., et al. A multicenter study of recombinant human erythropoietin (epoetin alpha) in the management of anemia in cancer patients receiving chemotherapy. Anticancer Drugs. 8:(10):1997;949-957.
6. Glaspy J., Bukowski R., Steinberg D., et al. Impact of therapy with epoetin alpha on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol. 15:(3):1997;1218-1234.
7. Demetri G., Kris M., Wade J., et al. Quality of life benefit in chemotherapy patients treated with epoetin alpha is independent of disease response or tumor type: results from a prospective community oncology study. J Clin Oncol. 16:(10):1998;3412-3425.
8. Gabrilove J., Cleeland C., Livingston R., et al. Clinical evaluation of once weekly dosing of epoetin-alpha in chemotherapy: improvements in hemoglobin and quality of life are similar in three times weekly dosing. J Clin Oncol. 19:(11):2001;2875-2882.
9. Littlewood T., Bajetta E., Nortier J., et al. Effects of epoetin alpha on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind placebo controlled trial. J Clin Oncol. 19:(11):2001;2865-2874.
10. Dusenberry K., McGuire W., Holt P., et al. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer. Int J Radiat Oncol Bio-Physics. 29:(5):1994;1079-1084.
11. Abels R.I., Larholt K., Krantz K., Bryant E. Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia of cancer. Blood cell growth factors: their present and future use in hematology and oncology. 1991;Alpha Med Press, Dayton, OH.
12. Levine M., Hirsh J., Gent M., et al. Double-blind randomized trial of very low dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet. 343:1994;886-889.
13. Saphner T., Tormey D., Gray R. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol. 9:(2):1991;286-294.
14. Clahsen P., van de Velde C., Julien J., et al. Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European organization for research and treatment of cancer breast cancer cooperative group study. J Clin Oncol. 12:(6):1994;1266-1271.
15. Goodnough L., Saito H., Manni A., et al. Increased incidence of thromboembolism is Stage IV breast cancer patients treated with a 5 drug chemotherapy regimen. Cancer. 54:1984;1264-1268.